L’Oreal’s Gunslinging Counsel On Killing Amla Hair-Relaxer Class Action: ‘We Shot Every Bullet’
Executive Summary
Gordon & Rees partner Peter Siachos for L’Oreal says the firm was “relentless” in its defense against a consolidated class action in New York’s Southern District concerning the SoftSheen Carson Amla Legend hair relaxer. Plaintiffs alleged the product is unreasonably dangerous and, at the same time, deceptively marketed as a gentler option than competing, lye-based offerings.
You may also be interested in...
MoCRA-Required Recordkeeping, Reporting Now ‘Fair Game’ For Litigants – Crowell & Moring
Cosmetic product manufacturers can expect the plaintiffs’ bar to leverage new record-keeping, GMP and other provisions of the Modernization of Cosmetic Regulations Act to bring or advance litigation, Crowell & Moring attorneys say. They note some defensive tactics that could prove effective.
CBD Beauty Claims Based On Third-Party Studies Could Be Litigation Targets – Venable Attorney
There’s a growing body of scientific evidence linking cannabidiol to benefits of interest to beauty industry players, but if a company’s CBD ingredient differs from the substance studied, that could be grounds for a false-advertising complaint. Venable partner Todd Halpern discusses.
Blood In The Water? L’Oreal Hit With New Keratin Fraud Complaint As Matrix Suit Advances
L’Oreal USA is in Phase II expert discovery in a certified class action alleging that the absence of keratin in its Matrix Biolage Keratindose hair-care line misleads consumers. Now the firm faces similar allegations, also in New York’s Southern District, about a L’Oreal Paris Keratin Caring range.